Former Medicon Valley Inhalation Consortium (MVIC) CEO Ola Nerbrink has joined PreciseInhale maker Inhalation Sciences (ISAB) as Senior Sales Advisor, the company said. Nerbrink, who stepped down as MVIC CEO earlier this year, founded Respiron Consulting in 2009 after having worked at AstraZeneca and Novo Nordisk.
The PreciseInhale system generates dry powder aerosols for pre-clinical and clinical research purposes.
ISAB CEO Fredrik Sjövall said, ”Ola’s international network in research and pharma is invaluable. He understands how to best connect medical and financial decision makers. We’ve received enormous interest in PreciseInhale amongst active researchers. We believe we can shorten sales time by more effectively supporting them in their relationship with economic decision makers.”
Nerbrink commented, ”I’m looking forward to working with Fredrik Sjövall, Per Gerde and the ISAB team. PreciseInhale is a unique system that fundamentally improves inhalation research, in the coming years it could make a big difference for both pharma companies and research institutes.”
Read the ISAB press release.
